###begin article-title 0
The Chemokine Receptor CXCR4 Strongly Promotes Neuroblastoma Primary Tumour and Metastatic Growth, but not Invasion
###end article-title 0
###begin p 1
Conceived and designed the experiments: NG RM JJ. Performed the experiments: CF CR RM FL KA KB ED JJ. Analyzed the data: NG RM AM MF AC. Contributed reagents/materials/analysis tools: GV. Wrote the paper: RM.
###end p 1
###begin p 2
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1042 1050 1042 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1072 1079 1072 1079 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 614 619 <span type="species:ncbi:10090">mouse</span>
###xml 1131 1136 <span type="species:ncbi:10090">mouse</span>
Neuroblastoma (NB) is a heterogeneous, and particularly malignant childhood neoplasm in its higher stages, with a propensity to form metastasis in selected organs, in particular liver and bone marrow, and for which there is still no efficient treatment available beyond surgery. Recent evidence indicates that the CXCR4/CXCL12 chemokine/receptor axis may be involved in promoting NB invasion and metastasis. In this study, we explored the potential role of CXCR4 in the malignant behaviour of NB, using a combination of in vitro functional analyses and in vivo growth and metastasis assessment in an orthotopic NB mouse model. We show here that CXCR4 overexpression in non-metastatic CXCR4-negative NB cells IGR-NB8 and in moderately metastatic, CXCR4 expressing NB cells IGR-N91, strongly increased tumour growth of primary tumours and liver metastases, without altering the frequency or the pattern of metastasis. Moreover shRNA-mediated knock-down experiments confirmed our observations by showing that silencing CXCR4 in NB cells impairs in vitro and almost abrogates in vivo growth. High levels of CXCL12 were detected in the mouse adrenal gland (the primary tumour site), and in the liver suggesting a paracrine effect of host-derived CXCL12 on NB growth. In conclusion, this study reveals a yet unreported NB-specific predominant growth and survival-promoting role of CXCR4, which warrants a critical reconsideration of the role of CXCR4 in the malignant behaviour of NB and other cancers.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 403 406 403 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Brodeur1">[1]</xref>
###xml 706 709 706 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Hanahan1">[2]</xref>
###xml 711 714 711 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Liotta1">[3]</xref>
###xml 1123 1126 1123 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Baggiolini1">[4]</xref>
###xml 1127 1130 1127 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Zlotnik1">[6]</xref>
###xml 1241 1244 1241 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Muller1">[7]</xref>
###xml 1246 1249 1246 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill1">[8]</xref>
###xml 1393 1396 1393 1396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill2">[9]</xref>
###xml 1464 1468 1464 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill3">[10]</xref>
###xml 1551 1554 1551 1554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill2">[9]</xref>
###xml 1556 1560 1556 1560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Marchesi1">[11]</xref>
###xml 1740 1744 1740 1744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Zhang1">[12]</xref>
###xml 1810 1814 1810 1814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Airoldi1">[13]</xref>
###xml 245 253 <span type="species:ncbi:9606">patients</span>
Neuroblastoma (NB), the most common and deadly solid tumour in childhood, originates from primitive cells of the sympathetic nervous system. NB displays a very heterogeneous behaviour at clinical, biological, and genetic levels. The majority of patients presents at diagnosis with an aggressive and metastatic disease for which little improvement in therapeutic options has been made in the last decade [1]. Metastatic tumour cell dissemination of advanced stage and highly malignant NB tumours mainly occurs in the bone marrow, bone, liver, and skin. Organ-specific metastasis, known to involve events in both the tumour cells and the target tissue, represents an intriguing and yet unresolved phenomenon [2], [3]. Chemokines are small, cytokine-like proteins forming a large superfamily, originally discovered as essential mediators of leukocyte chemoattraction in inflammation and immune cell homing and recirculation. Upon binding to their cognate seven-transmembrane spanning G-protein-coupled receptors, they induce integrin activation and cytoskeletal rearrangement promoting cell adhesion and directional migration [4]-[6]. Emerging evidence indicates that the chemokines and their receptors play an important role in tumour biology [7], [8]. CXCR4 is the chemokine receptor most commonly found on tumour cells. It has been reported expressed in at least 23 different types of cancers [9]. In a number of cancer types, binding of its cognate ligand CXCL12 [10] was reported to mediate directed migration of cancer cells to sites of metastasis [9], [11]. Recent reports indicate that CXCR4 is commonly expressed on NB metastasis in the bone marrow and that it may be actively contributing to NB tumour cell homing to the bone marrow [12]. However, these observations are still controversially discussed [13].
###end p 4
###begin p 5
###xml 274 278 274 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Kaplan1">[14]</xref>
###xml 298 305 298 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Khanna1">[15]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Valteau1">[18]</xref>
There is emerging evidence that the tumour environment plays a critical role in modulating the behaviour of primary or metastatic tumour cells. The appropriate microenvironment and vascular niche involved in metastasis initiation can only be provided by the orthotopic site [14]. Hence, the use of in vivo orthotopic models, faithfully reproducing the tumour microenvironment, is essential for the analysis of metastasis-related mechanisms [15]-[18].
###end p 5
###begin p 6
###xml 75 83 75 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 88 95 88 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 216 223 216 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
In this study, we investigated the contribution of CXCR4 to NB progression in vitro and in vivo and demonstrate that CXCR4 overexpression promotes NB primary and secondary tumour growth but not NB invasion. Using an in vivo orthotopic model [19], we demonstrate that CXCR4 has no significant influence on the number or pattern of NB metastasis. In contrast, the strong growth-promoting effect observed may represent the main role of CXCR4 in tumour progression. These results warrant a critical reconsideration of the role of CXCR4 in NB tumour progression.
###end p 6
###begin title 7
Materials and Methods
###end title 7
###begin title 8
Cell lines and culture
###end title 8
###begin p 9
###xml 81 85 81 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Valteau1">[18]</xref>
###xml 159 163 159 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Ferrandis1">[20]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Geminder1">[21]</xref>
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 732 736 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 738 742 734 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Bottenstein1">[23]</xref>
###xml 54 59 <span type="species:ncbi:9606">human</span>
###xml 547 551 <span type="species:ncbi:9913">calf</span>
IGR-NB8 cell line was derived from a xenotransplanted human stage 3 abdominal NB [18]. IGR-N91 cell line was derived from a stage 4 NB infiltrated bone marrow [20]. The cell line SH-SY5Y was used as a CXCR4 positive control [21]. The prostate cancer cell line PC3, represents another positive control for its described and generally accepted properties upon CXCR4 overexpression [22]. Unless specified, cells were cultured in Dubelcco's modified Eagle's medium (DMEM) supplemented with 2 mmol/l L-glutamine, 10 microg/ml gentamycin, and 10% fetal calf serum (FCS) (AMIMED). For growth and invasion assays, cells were cultured in N2-supplemented DMEM, a serum-free medium specifically defined to support the growth of neuronal cells [22], [23]
###end p 9
###begin title 10
CXCR4 overexpression
###end title 10
###begin p 11
###xml 235 239 235 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 308 312 308 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Zhang1">[12]</xref>
A pMIGR-EGFP vector encoding for the enhanced green fluorescent protein (EGFP) with or without the chemokine receptor CXCR4 gene was inserted by retroviral mediated infection into IGR-NB8, IGR-N91 and PC3 cells as previously described [19]. The CXCR4 containing plasmid was sequenced to verify its integrity [12].
###end p 11
###begin p 12
GFP-overexpressing cells were sorted by fluorescence activated cell sorting (FACS) and cloned. Control GFP and selected CXCR4 clones were analysed by FACScan (Becton Dickinson), using the PE-labelled 12G5 monoclonal antibody from BD Pharmingen to measure and quantify CXCR4 surface expression levels.
###end p 12
###begin title 13
In vivo growth
###end title 13
###begin p 14
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 348 349 344 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 130 139 <span type="species:ncbi:10090">nude mice</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
Animal engraftments, tumour and metastases growth records were performed as previously described [19]. Athymic locally bred Swiss nude mice were engrafted with 6x105 of NB8-E6 (8 animals), NB8-CXCR4-C3 (8 animals), N91-E2 (8 animals), and N91-CXCR4-14 (13 animals) cells in 15 microl DMEM in the left adrenal gland. For knock-down experiments, 2x106 N91-pAB303, N91-shCXCR4-CS1 and N91-shCXCR4-CS2 cells in 50 microl DMEM were injected. Ten animals were used for each group. One mouse in the N91-pAB303, 4 in the N91-shCXCR4-CS1 and 2 in the N91-shCXCR4-CS2 group died of perioperative complications.
###end p 14
###begin p 15
###xml 132 136 132 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
Micrometastases were detected by PCR and macroscopic metastases by morphological examination and/or GFP-IHC as previously described [19].
###end p 15
###begin title 16
Cell proliferation assay
###end title 16
###begin p 17
###xml 107 111 107 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-BaumannKubetzko1">[24]</xref>
Cell proliferation was assessed using the MTS/PMS cell proliferation kit from Promega as described earlier [24]. Twenty thousand cells per well were seeded in either 10% FCS or 2% FCS. Where indicated, growth assays were performed in the presence of CXCL12 (100 ng/ml).
###end p 17
###begin title 18
ERK1/2 phosphorylation
###end title 18
###begin p 19
###xml 13 17 13 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Hasmim1">[25]</xref>
###xml 119 120 119 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
As described [25], cells were serum-starved overnight and washed once with PBS prior to experimentation. Aliquots of 106 cells were stimulated with CXCL12 (Preprotech) for indicated time. Incubations were stopped by the addition of 500 microl SDS-PAGE buffer. To detect phospho-ERK1/2, membranes were first probed with a phospho-specific antibody (Cell Signalling) and then stripped and re-probed with the antibody against the total ERK1/2.
###end p 19
###begin title 20
CXCL12 ELISA
###end title 20
###begin p 21
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Calvet1">[26]</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
An ELISA assay (R&D Systems) was used to quantify the production of CXCL12 by NB cell lines, normal mice tissues, and orthotopically grown primary tumours. Tissue extracts were prepared as described [26] and were processed following R&D Systems's instructions.
###end p 21
###begin title 22
Chemotaxis and invasion assays
###end title 22
###begin p 23
###xml 140 141 134 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 261 265 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Sabri1">[27]</xref>
###xml 461 465 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Tamamura1">[28]</xref>
Cell migration was measured using Transwell Costar(R) cell culture chambers with polycarbonate filters of 8 microM porosity. Briefly, 2.5x105 cells suspended in serum-free medium (SFM) were seeded in the upper compartment of a two chambers system, as described [27]. The lower compartment was filled with SFM with or without 100 ng/ml CXCL12. Migration assays were performed in the presence or absence of a specific CXCR4 receptor inhibitor, 4F-benzoyl-TN14003 [28]. The cells were allowed to settle down for 4 hours. After washing, membranes were fixed with 4% paraformaldehyde in PBS for 10 min and stained with haematoxylin. Non migrated cells were scraped from the upper side of the filter, and migrated cells on the lower side counted by light microscopy.
###end p 23
###begin p 24
For invasion assays, the 8 microm polycarbonate membranes of the Transwell inserts were coated with 50 microl of 0.8 mg/ml of Matrigel(R). The lower chamber was either supplemented with DMEM-N2 medium alone or with DMEM-N2-containing 100 ng/ml CXCL12. Fifty thousand overnight serum-starved cells were plated in the upper chamber. After 48 h incubation at 37degreesC, membranes were processed and number of invading cells counted as above.
###end p 24
###begin title 25
Knock-down of CXCR4 by shRNA
###end title 25
###begin p 26
###xml 89 93 89 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Brummelkamp1">[29]</xref>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Wang1">[30]</xref>
###xml 221 225 221 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Flahaut1">[31]</xref>
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Bridge1">[32]</xref>
###xml 670 674 670 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Bridge1">[32]</xref>
###xml 451 455 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Stable downregulation of CXCR4 was achieved by RNA interference using short hairpin RNAs [29]. A published sequence from shRNA which specifically and efficiently down regulates CXCR4 was used as previously reported [30], [31]. The sequences were checked by sequencing a PCR-amplified region containing the oligonucleotide. The H1 promoter and the shRNA cassette were sub-cloned into the BamHI/SalI sites of the lentiviral vector pAB286 containing the SV40 promoter-puromycin acetyltransferase cassette [32]. The pAB303 lentiviral vector which contains the H1 promoter alone, without shRNA sequence, was used as a negative control (gift from R. Iggo, Aberdeen, Scotland) [32]. Lentiviruses were produced by co-transducing the lentiviral vector plasmid containing the shRNA (10 microg) and the second generation packaging plasmids (3.5 microg pMD2-VSVG, 6.5 microg pCMVDeltaR8.91) into 293T (ATCC CRL-11268) all vectors but pAB303 kindly provided from D. Trono, EPFL, Lausanne, Switzerland. Infection of target cells were done by over-night incubation at 37degreesC in virus-containing media in presence of 8 microg/ml polybrene (hexadimethrindibromide, Fluka). Twenty-four hours post-transfection, the lentivirus containing supernatant was used to infect the IGR-N91 cell line. Selection was started 48 h after infection with 5 microg/ml puromycin (Sigma-Aldrich, Steinheim, Germany). Puromycin resistant infected cells were selected 24 h post-infection.
###end p 26
###begin p 27
CXCR4 protein expression knock-down in shRNA-transduced cells was determined by FACS analyses.
###end p 27
###begin title 28
Statistical analyses
###end title 28
###begin p 29
###xml 379 386 379 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Statistcial analyses were performed using GraphPadPrism 4.0. Two-way ANOVA with Bonferroni post-test corrections was performed to compare cell growth in 10% and 2% FCS. Student's t test was performed for cell growth in the presence or absence of CXCL12. Fisher's exact test was performed to compare the number of metastasis-bearing animals. Mann-Whitney test was used to compare in vivo tumour growth. A p<0.05 was considered to represent signficance and p<0.01 was considered to be highly significant.
###end p 29
###begin title 30
Results
###end title 30
###begin title 31
Expression of the chemokine receptor CXCR4 on NB cell lines
###end title 31
###begin p 32
###xml 170 178 170 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g001">Figure 1</xref>
Constitutive cell surface CXCR4 expression, measured by flow cytometry (FC) in a panel of NB cell lines was variable among the cell lines tested (not shown). As shown in Figure 1, two selected invasive NB cell lines, IGR-N91, SH-SY5Y, displayed constitutive levels of CXCR4 surface protein expression (54% and 97% positive cells respectively), while the non-invasive IGR-NB8 cell line expressed very little if any surface CXCR4 (1.48% positive cells).
###end p 32
###begin title 33
CXCR4 cell surface expression.
###end title 33
###begin p 34
###xml 379 383 379 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Geminder1">[21]</xref>
IGR-NB8 and IGR-N91, two well characterized NB cell lines, and transduced cell lines/clones were analyzed for their cell surface CXCR4 expression by flow cytometry (FACS). Percent positive cells is indicated as well as the mean fluorescent intensity (brackets) of the CXCR4 staining. The NB cell line SH-SY5Y constitutively expressed high levels of CXCR4 as previously described [21]. The prostate cancer cell line PC3 showed comparable levels of CXCR4 expression upon transduction as NB8-CXCR4 and N91-CXCR4 clones.
###end p 34
###begin p 35
###xml 284 288 284 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 617 625 617 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g001">Figure 1</xref>
To explore the putative role of CXCR4 in NB malignant behaviour, we stably overexpressed CXCR4 by retroviral transduction in two NB cell lines with well-characterized growth properties: IGR-NB8, a non metastatic line, and IGR-N91, which forms metastases when implanted orthotopically [19]. CXCR4-transduced clones, randomly selected from IGR-NB8 (NB8-CXCR4-B2, C3, and -E9) or IGR-N91 (N91-CXCR4-11, -14, -19), displayed high and similar levels of surface CXCR4 expression. Mock transduced NB8-E6 cells remained CXCR4 negative, while and N91-E2 cells express slightly lower levels of CXCR4 compared to parent cells. (Figure 1).
###end p 35
###begin title 36
CXCR4 increases IGR-NB8 in vivo growth
###end title 36
###begin p 37
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 103 108 <span type="species:ncbi:10090">mouse</span>
To evaluate the role of CXCR4 in the development of site-specific metastasis we used the orthotopic NB mouse model that strongly implies the role of the tumour microenvironment on tumour progression. Parental lines and CXCR4 transduced clones were analysed in vivo for primary (orthoptopic) tumour growth, metastatic dissemination, and organ specific secondary growth.
###end p 37
###begin p 38
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 637 646 637 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2a</xref>
###xml 299 308 <span type="species:ncbi:10090">nude mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 459 463 <span type="species:ncbi:10090">mice</span>
###xml 569 573 <span type="species:ncbi:10090">mice</span>
In vivo experiments were first performed with the NB8-E6 cells, previously shown to be able to induce tumours in the orthotopic model, but unable to develop metastases. Two randomly selected control NB8-E6 and CXCR4-overexpressing NB8-CXCR4-C3 cell lines were implanted in the left adrenal gland of nude mice. The mice were examined by echography at day 33, 53, 69, and 102 for the presence of tumours. Six out of 8 animals (75%) in the NB8-E6 group, and 7/8 mice (88%) in the group engrafted with NB8-CXCR4-C3 developed a tumour, thus showing a similar tumour take in mice engrafted with CXCR4-negative or CXCR4 positive NB8 cell line (Figure 2a).
###end p 38
###begin title 39
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo orthotopic tumour growth and metastasis.
###end title 39
###begin p 40
###xml 26 30 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 293 297 <span type="species:ncbi:10090">mice</span>
###xml 364 368 <span type="species:ncbi:10090">mice</span>
###xml 617 621 <span type="species:ncbi:10090">mice</span>
Tumour growth measured in mice engrafted with NB8-E6 and NB8-CXCR4-C3 (a), and N91-E2 and N91-CXCR4-14 (c) The mean tumour volume +/- S.D. as measured by echo-doppler at indicated days after implantation is shown. The tumour take expressed as number of mice with tumour/total mice and percent mice with tumours is indicated. (b) and (d) Detection of metastases in mice engrafted with either NB8-E6/NB8-CXCR4-C3 or N91-E2/N91-CXCR4-14 cells. Macroscopic liver metastases were detected by gross examination. Micrometastases were detected in lung, bone marrow, muscle and blood by GFP-PCR. Bars represent percentages of mice with macroscopic liver metastases or GFP-PCR positive signals in indicated organs per tumour bearing animal.
###end p 40
###begin p 41
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2a</xref>
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 680 681 680 681 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 990 997 990 997 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 999 1008 999 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2a</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
###xml 402 406 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
As shown in Figure 2a, CXCR4 expression in the NB8 cell line dramatically accelerated tumour growth. The first echographic record performed at day 33 after implantation, already revealed the presence of tumours with a volume between 100 and 200 mm3 in two mice in the NB8-CXCR4-C3 group, whereas no tumours were detected in the control group. At day 53, 7/8 mice in the NB8-CXCR4-C3-implanted group of mice had developed tumours with a mean volume of 1727 mm3, which required the immediate sacrifice of all animals in this group, while in the control group tumours were barely detectable at that time point. At sacrifice (day 102), the mean volume of NB8-E6 tumours was only 48 mm3. These results reveal that the time interval between engraftment and detectable tumour growth was considerably reduced in mice engrafted with NB8-CXCR4-C3 cells compared to NB8-E6, thus demonstrating that CXCR4 expression in the CXCR4-negative cell line NB8 dramatically accelerated orthotopic tumour growth in vivo (Figure 2a).
###end p 41
###begin title 42
CXCR4 does not induce metastatic dissemination of IGR-NB8 cells
###end title 42
###begin p 43
###xml 112 116 112 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Geminder1">[21]</xref>
###xml 249 256 249 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 748 757 748 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2b</xref>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 764 768 <span type="species:ncbi:10090">mice</span>
One of the major proposed contribution of CXCR4 to NB progression was the promotion of site-specific metastasis [21]. We therefore investigated whether CXCR4 overexpression in NB tumour cells could influence organ-specific invasive behaviour in our in vivo model. Major target and control organs of tumour-bearing mice were macroscopically analysed for the presence of metastases. No macroscopic metastasis was detected in either group. Micrometastases as detected by GFP-PCR-based analysis, revealed GFP-signals in the lungs of a minority of NB8-E6 and NB8-CXCR4-C3-engrafted animals, and in the livers of 2/6 NB8-E6 and 4/7 NB8-CXCR4-C3 bearing animals, respectively. No signal was found in blood, muscle, and bone marrow of both groups of mice (Figure 2b). All mice livers were further investigated by GFP-immuno-histochemistry where no microscopic metastasis was detected (data not shown).
###end p 43
###begin p 44
These results indicated that enhanced CXCR4 expression in the IGR-NB8 cells tremendously accelerated the growth of the primary tumour. In contrast, CXCR4 overexpression was not sufficient to induce metastatic dissemination in this orthotopic model.
###end p 44
###begin title 45
CXCR4 increases IGR-N91 in vivo growth
###end title 45
###begin p 46
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 570 571 570 571 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 669 670 669 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 686 695 686 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2c</xref>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
Since the IGR-NB8 cell line is a non-metastatic cell-line we were concerned that it may lack essential invasive elements, thereby masking a potential metastasis-promoting effect of CXCR4. We therefore repeated the experiment with IGR-N91, a cell line which is capable of forming metastases when injected orthotopically, but not when injected s.c. [19]. Specifically, we injected the CXCR4 overexpressing cell line N91-CXCR4-14 and N91-E2, the mock-transduced control. Out of 13 mice implanted with N91-CXCR4-14 cells, 12 developed a tumour, with a mean volume of 1390 mm3 at 49 days, whereas in the control group, 8/8 developed a tumour, reaching a mean volume of 15 mm3 after 49 days (Figure 2c). As observed with the IGR-NB8 derived cells, the tumour take was similar in both groups. N91-CXCR4 tumours also grew considerably faster, reaching nearly 100 fold larger volumes than N91-E2 tumours.
###end p 46
###begin title 47
CXCR4 does not enhance metastatic dissemination of IGR-N91 cells
###end title 47
###begin p 48
###xml 236 245 236 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2d</xref>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
###xml 513 517 <span type="species:ncbi:10090">mice</span>
The examination of the metastatic pattern of these tumours revealed that 6/12 mice in the N91-CXCR4-14 group had at least one macroscopic liver metastasis, whereas in the control group 2/8 mice developed macroscopic hepatic metastases (Figure 2d). The volume of liver metastases in N91-CXCR4-engrafted group of mice was much larger (250 to 1000 mm3) when compared to the N91-E2 group (less that 100 mm3). GFP-PCR analyses revealed the presence of micrometastases in 58% of the lungs and 50% in the bone marrow of mice with N91-CXCR4-14 tumours, versus 50% and 25% in the N91-E2 group. These differences observed in the occurrence of micro- and macro-metastases were nevertheless not statistically significant (Fisher's exact test: p = 0.38), while the differences in the volume of macroscopic liver metastases in the two groups were highly significant. No GFP-PCR signal was detected in the blood or in the control organ (muscle) in either group.
###end p 48
###begin p 49
These results reveal that CXCR4 overexpression in the metastasis-competent IGR-91 NB cells has a strong and predominant effect on primary and secondary tumour growth (increase of the metastases volume). Even in such orthotopic model, a statistically significant increase of metastases frequency could not be demonstrated.
###end p 49
###begin title 50
Functional CXCR4 supports in vitro NB cell growth and survival
###end title 50
###begin p 51
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
To gain further insight into the distinct molecular mechanisms responsible for the CXCR4/CXCL12 axis mediated effects on NB progression rather than site-specific invasion, we next explored the effects of CXCR4 over-expression on in vitro proliferation, survival, migration, and invasion of these NB cells.
###end p 51
###begin p 52
###xml 78 86 78 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 150 159 150 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3a</xref>
###xml 482 491 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3a</xref>
###xml 499 507 499 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 783 792 783 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3b</xref>
The growth and survival of different CXCR4-expressing cell lines was measured in vitro in complete medium (10% FCS) or in stress conditions (2% FCS) (Figure 3a). Growth curves were established over a 96 hours period. In the presence of 10% FCS, the results revealed a non significant difference in the growth capacity of 2 NB8-CXCR4-expressing clones as compared to NB8-E6. A significantly enhanced growth of one clone (NB8-CXCR4-E9) as compared to the control cells was observed. (Figure 3a). Thus in vitro, the IGR-NB8-E6 and NB8-CXCR4-C3 cells selected for in vivo studies, did not show different growth properties. In contrast, addition of the CXCL12 ligand significantly increased the growth of CXCR4-overexpressing NB8-CXCR4-C3 cells, but not that of the control NB8-E6 cells (Figure 3b).
###end p 52
###begin title 53
Effect of functional CXCR4 overexpression in NB cell lines.
###end title 53
###begin p 54
###xml 5 12 5 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n vitro</italic>
###xml 246 254 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
(a) In vitro growth of NB8-E6, NB8-CXCR4-C3, -B2, and -E9 cells, in 10% (black squares) or 2% serum (open squares). (statistical analysis by two-way ANOVA and Bonferroni correction) A representative of three independent experiments is shown. (b) In vitro growth of NB8-E6 and NB8-CXCR4-C3 cells in the presence of 100 ng/ml CXCL12 (black squares) or in medium alone (open squares). (c) Western blot analysis of ERK1/2 phosphorylation in response to CXCL12 in CXCR4-transduced cells.
###end p 54
###begin p 55
###xml 337 346 337 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3b</xref>
The CXCR4-expressing clones and their controls were exposed to suboptimal culture conditions (2% FCS). These stress conditions significantly impaired NB8-E6 growth, while they only slightly affected the growth of the three CXCR4 expressing clones, indicating a significant (p<0.05) CXCR4-mediated enhanced survival in stress conditions (Figure 3b).
###end p 55
###begin p 56
###xml 73 81 73 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
CXCR4 overexpression in the IGR-N91 cells did not further increase their in vitro growth or survival (not shown).
###end p 56
###begin p 57
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 328 337 328 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3c</xref>
###xml 736 745 736 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g003">Figure 3c</xref>
Extracellular regulated kinases (ERK) 1/2 are activated by phosphorylation in response to various extracellular signals, including the binding of CXCR4 to its unique ligand, CXCL12, [22]. To test the functionality of endogenous and transduced CXCR4 in NB cells, we monitored CXCL12-mediated ERK 1/2 phosphorylation. As shown in Figure 3c, no significant increase in ERK1/2 phosphorylation was detected in the control NB8-E6 cells in response to CXCL12 up to 30 minutes. In contrast, in N91-E2, expressing endogeneous CXCR4 and in NB8-CXCR4-C3, and N91-CXCR4-14 cells with exogeneous CXCR4 overexpression, CXCL12 stimulation increased ERK1/2 phosphorylation already after 1 minute. Total ERK1/2 protein was unchanged at all time points (Figure 3c). Altogether these assays confirmed that the CXCR4 receptor, either endogenous or exogenous, is functional and able to transduce CXCL12-mediated intracellular signals in NB cells, implicating the ERK pathway as potential mediator of CXCR4-induced proliferation.
###end p 57
###begin title 58
CXCR4 induces cell migration in response to CXCL12
###end title 58
###begin p 59
###xml 149 158 145 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g004">Figure 4a</xref>
We next tested whether CXCR4 increased directed migration. To this purpose, CXCL12-mediated cell migration was measured in NB cells. Alphas shown in Figure 4a, none of the cell lines were able to migrate in the absence of the ligand. In the presence of 100 ng/ml of CXCL12, migration was induced in IGR-N91 cells and in all three NB8-CXCR4 clones but not in the CXCR4-negative NB8-E6 cells. Migration of N91-CXCR4-14 clone was not enhanced as compared to that of N91-E2 control cells in response to CXCL12.
###end p 59
###begin p 60
###xml 249 258 247 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g004">Figure 4a</xref>
Migration assays were then performed in the presence of CXCL12 +/- the CXCR4 TN14003 inhibitor. TN14003 did not alter the migration of the control NB8-E6 cell line, but it attenuated chemotaxis of CXCR4-expressing clones in a dose-dependent manner (Figure 4a), indicating a specific CXCR4-promoting chemotaxis in IGR-NB8 and IGR-N91 cells.
###end p 60
###begin title 61
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
NB8 cell migration and invasion in vitro.
###end title 61
###begin p 62
(a) Migration of NB8-E6, N91-E2, and CXCR4-overexpressing clones (NB8-CXCR4-C3, -B2, -E9, N91-CXCR4-14) towards CXCL12, in absence or presence of the CXCR4 blocker (TN14003 inhibitor). Results of a representative experiment are shown and are expressed as mean number of cells in one field. Five fields were counted for each result. The experiment was performed in triplicates and repeated three times. Error bars indicate S.D. (b) Invasion of SH-SY5Y, NB8 and N91 control and CXCR4 transduced clones through Matrigel(R)-coated membranes in N2 supplemented serum-free medium alone, with or without CXCL12. CXCL12-mediated invading cells (invaded cell in the absence of CXCL12 have been subtracted) -in a typical field are shown. The mean number of invading cells in 5 fields is given. Error bars indicate S.D. (* indicates p<0.05, Student's t-test)
###end p 62
###begin title 63
CXCR4 does not mediate in vitro invasion of NB cells in response to CXCL12
###end title 63
###begin p 64
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 476 480 470 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Cui1">[33]</xref>
In order to form metastases in vivo, malignant cells need not only to migrate, but also to invade basal membranes and the surrounding tissue. To investigate the role of CXCR4/CXCL12 axis in promoting cell invasion we performed an in vitro Matrigel(R) invasion assay. The different cell lines were placed in the upper chamber of a Transwell(R) filter coated with Matrigel(R), and cells were allowed to invade for 48 hours in response to CXCL12 present in the lower compartment [33].
###end p 64
###begin p 65
###xml 12 21 12 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g004">Figure 4b</xref>
###xml 272 281 272 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g004">Figure 4b</xref>
###xml 388 392 388 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 524 532 524 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 553 562 553 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g004">Figure 4b</xref>
###xml 698 706 698 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g001">Figure 1</xref>
As shown in Figure 4b, none of the cell lines were invasive in serum free, N2-supplemented medium, whereas control cells SH-SY5Y were invasive in these conditions. In the presence of CXCL12, the N91-E2 cells were only slightly invasive, whereas the NB8-E6 cells were not (Figure 4b). As a control, the prostate cancer cell line PC3, reported to be more invasive when overexpressing CXCR4 [22] was transduced with the same CXCR4 containing plasmid. The CXCR4 transduced cells PC3-CXCR4 cells were significantly more invasive in vitro than control cells (Figure 4b) (Student's t-test: p<0.05). However, despite high and similar CXCR4 induced surface expression in NB8-CXCR4, N91-CXCR4 and PC3 cells (Figure 1), the invasive capacity of NB8-CXCR4 and N91-CXCR4 cells was not significantly enhanced as compared to control mock-transduced cells, while significant enhanced invasion of CXCR4-PC3 cells was observed. This suggests a tumour type specific effect of CXCR4 in promoting invasion.
###end p 65
###begin p 66
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 388 397 388 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001016.s001">Figure S1</xref>
###xml 518 527 518 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0001016.s001">Figure S1</xref>
As NB8-CXCR4 overexpressing cells displayed enhanced in vitro migration but not invasion nor in vivo metastatic dissemination, we investigated whether the lack of invasive properties was due to a lack of proteolytic activities in the NB8 or N91 cells by measuring MMP-2 and -9 activities in SH-SY5Y cells culture supernatant, N91-E2, NB8-E6 and NB8-CXCR4 clones using a zymography assay (Figure S1). Data obtained ruled out an implication of MMP-2 and MMP-9 in the lack of metastatic properties of NB8 cell line used (Figure S1).
###end p 66
###begin title 67
The CXCR4 ligand, CXCL12 is produced by the tumour microenvironment
###end title 67
###begin p 68
###xml 58 65 58 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 324 332 324 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g005">Figure 5</xref>
###xml 682 690 682 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g005">Figure 5</xref>
###xml 397 402 <span type="species:ncbi:10090">mouse</span>
The above data indicate that CXCR4 enhances tumour growth in vivo and NB cell proliferation in vitro in response to CXCL12. To collect evidence whether CXCL12 may be a factor relevant to tumour growth in vivo, we measured the concentration of CXCL12 in the primary and secondary tumours as well as in selected host tissues (Figure 5). Presence of CXCL12 could be measured by ELISA in several nude mouse organs, and the highest levels of CXCL12 were found in the adrenal gland, the natural primary tumour microenvironment for neuroblastoma. High CXCL12 levels where also found in the liver, lung and muscle, while almost undetectable CXCL12 were measured in bone marrow (not shown) (Figure 5). Surprisingly, no direct relationship was observed between expression levels of CXCL12 in the different organs and the pattern of NB metastasis. In contrast, the high levels of CXCL12 detected in the adrenal glands and liver, may be related to the increased primary NB tumour and secondary metastatic growth in these tissues.
###end p 68
###begin title 69
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
CXCL12 production in mouse tissues and NB tumours.
###end title 69
###begin p 70
###xml 57 62 <span type="species:ncbi:10090">mouse</span>
The production of CXCL12 was measured by ELISA in normal mouse tissues, as well as in the different clones, and primary tumours. Results of triplicates are expressed as pg of CXCL12 per mg of extracted protein. One representative of three independent experiment is shown. Experiments were performed in triplicates.
###end p 70
###begin title 71
Knockdown of CXCR4 by shRNA
###end title 71
###begin p 72
###xml 685 694 685 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g006">Figure 6a</xref>
In order to confirm the specific role of CXCR4 in NB, we analysed the growth properties of CXCR4 knock-down cells. Since we observed that in vitro growth, migration and invasion were not further enhanced by exogeneous CXCR4 overexpression in IGR-N91 cells with conctitutive endogeneous CXCR4 expression, we knocked-down endogeneous CXCR4 in IGR-N91 cells. Stable knock-down of CXCR4 was achieved by transduction of IGR-N91 cells with shRNA lentiviral constructs. Clones were screened for efficient silencing of CXCR4 by real-time PCR. CXCR4 mRNA levels of cells transduced with the empty vector pAB303 were used as reference. Resulting cell surface CXCR4 expression, as illustrated in Figure 6a, shows that strong and efficient knock-down of CXCR4 was achieved in both N91-shRNA-CS1 and N91-shRNA-CS2 clones as compared to N91-pAB303 control cells (5.3% and 7.7% vs 53% CXCR4 positive cells respectively).
###end p 72
###begin p 73
###xml 253 261 253 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 353 360 353 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 487 491 <span type="species:ncbi:10090">mice</span>
(a) FACS profiles of shRNA-mediated cell surface CXCR4 silencing in N91-shRNA-CS1 and N91-shRNA-CS2 clones and N91-pAB303 control cells. Percent positive cells is indicated as well as the mean fluorescent intensity (brackets) of the CXCR4 staining. (b) In vitro growth capacities of N91-shRNA-CS1, N91-shRNA-CS2 clones and N91-pAB303 control cells. (c) In vivo growth capacities of IGR-N91 cells were CXCR4 has been knocked down by shRNA. Comparison of tumour volumes after 44 days when mice were sacrificed. * indicates p<0.05 (Mann-Whitney test).
###end p 73
###begin title 74
Knockdown of CXCR4 impairs in vitro growth
###end title 74
###begin p 75
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 100 107 100 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 194 202 194 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g006">figure 6b</xref>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 470 476 470 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g006">Fig 6b</xref>
CXCR4 overexpression in NB cells increased in vitro cell growth under serum deprived conditions and in vivo tumour growth. Cells where CXCR4 has been knocked down by shRNA were tested for their in vitro growth capacities. As shown in figure 6b, Both N91-shCXCR4-CS clones revealed impaired in vitro growth, not only in serum deprived culture conditions (2% FCS) but also in normal conditions (10% FCS). Interestingly the difference was only apparent at time point 96 h (Fig 6b).
###end p 75
###begin title 76
Knockdown of CXCR4 abrogates in vivo growth
###end title 76
###begin p 77
###xml 38 45 38 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 374 383 374 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g006">figure 6c</xref>
###xml 460 461 460 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 551 552 551 552 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 563 565 563 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3 </sup>
###xml 185 194 <span type="species:ncbi:10090">nude mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
We then specifically investigated the in vivo growth capacities of control N91-pAB303, N91-shCXCR4-CS1 and N91-shCXCR4-CS2 cells. For this purpose cells were orthotopically injected in nude mice and tumour growth measured every other week. In this experiment, all mice were sacrificed at day 44 when large tumours were present in the control group (N91-pAB303). As shown in figure 6c, at day 44, N91-pAB303 tumours were significantly larger (mean volume 703 mm3) than CXCR4 knocked-down N91-shCXCR4-CS1 and N91-shCXCR4-CS2 tumours (mean volume 74.8 mm3 and 9.7 mm3 respectively) (p<0.05 Mann Whitney test).
###end p 77
###begin title 78
Discussion
###end title 78
###begin p 79
###xml 312 315 312 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Muller1">[7]</xref>
###xml 316 319 316 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill2">[9]</xref>
###xml 321 325 321 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Ehtesham1">[34]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Mori1">[38]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Airoldi1">[13]</xref>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Zhang1">[12]</xref>
###xml 649 653 649 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Geminder1">[21]</xref>
###xml 885 889 885 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Airoldi1">[13]</xref>
###xml 691 699 <span type="species:ncbi:9606">patients</span>
Recent reports suggest a role for CXCR4 and its ligand CXCL12 in the malignant behaviour of cancer cells. In particular, the CXCR4/CXCL12 axis has been involved in metastasis formation, increased survival of cancer cells under harsh conditions, and establishment of a tumour promoting cytokine/chemokine network [7]-[9], [34]-[38]. The specific involvement of the CXCR4/CXCL12 axis in cell proliferation, and organ-specific metastasis has been partially addressed and remains controversial in some tumour systems, including NB [13]. It has been proposed that CXCR4 expression may be a mechanism by which NB cells metastasise at specific sites [12], [21]. A recent study on NB cell lines and patients samples, however, raised doubts on the implication of CXCR4 in the metastatic dissemination. Even though CXCR4 was expressed on bone marrow metastases, it appeared not to be functional [13].
###end p 79
###begin p 80
###xml 180 187 180 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 567 576 567 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro.</italic>
###xml 339 345 <span type="species:ncbi:10090">murine</span>
###xml 469 474 <span type="species:ncbi:9606">human</span>
The present study was initiated to address this controversial topic and to investigate the consequences of CXCR4 expression on growth and metastatic behaviour of two NB cell lines in vivo. The question whether CXCR4 is sufficient to initiate and to increase NB metastases upon orthotopic implantation has not been addressed yet. We used a murine orthotopic model of NB which implies the influence of the natural tumour microenvironment on tumour progression and mimics human NB behaviour [19]. The CXCR4/CXCL12 axis-mediated mechanisms were then further investigated in vitro.
###end p 80
###begin p 81
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 106 122 106 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2a and 2c</xref>
###xml 395 399 395 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 401 410 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0001016-g002">Figure 2d</xref>
###xml 774 777 774 777 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Campbell1">[5]</xref>
###xml 778 781 778 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Muller1">[7]</xref>
###xml 783 787 783 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Gerard1">[39]</xref>
###xml 788 792 788 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Scotton1">[41]</xref>
###xml 970 973 970 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Muller1">[7]</xref>
###xml 975 979 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 981 985 981 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Ehtesham1">[34]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-rashYahana1">[36]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Mori1">[38]</xref>
###xml 1216 1220 1214 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Wang1">[30]</xref>
###xml 1293 1297 1291 1295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 42 46 <span type="species:ncbi:10090">mice</span>
Our in vivo data indicate that almost all mice orthotopically engrafted with NB cells developed a tumour (Figure 2a and 2c). Surprisingly, overexpression of CXCR4 did not lead to induction of metastases in the non-metastatic NB cell line IGR-NB8 and did not increase the frequency of metastases formed by the metastatic IGR-N91 cell line, which constitutively expresses moderate levels of CXCR4 [19] (Figure 2d, Fisher's exact test: p = 0.38). CXCR4-overexpression in both cell lines, however, promoted a CXCL12-dependent chemotaxis, thereby demonstrating that in both cells lines ligand-bound CXCR4 can elicit a motility phenotype. This observation is consistent with previous reports linking CXCR4 expression with tumour cell motility and chemotaxis in response to CXCL12 [5]-[7], [39]-[41]. The controversial data on the influence of CXCR4 on metastasis frequency may be explained by the different in vivo assays used, as well as the different tumour types analysed. [7], [22], [34]-[36], [38]. While neither NB8-CXCR4 nor N91-CXCR4 clones showed any increased capacity to invade Matrigel(R) in response to CXCL12, CXCR4 overexpressing PC3 prostate cancer cells indeed showed increased in vitro invasive capacity [30]. This observation made in another cancer type confirms previous reports [22] and suggests that the pro-invasive effects of CXCR4 may be tumour type specific.
###end p 81
###begin p 82
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Zhang1">[12]</xref>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.v</italic>
On the other hand, increased metastatic capacity of CXCR4 expressing NB cells and increased CXCR4 expression in metastatic NB tumour cells as observed by Zhang et al. [12], may be explained by the i.v, implantation of tumour cells, thus focussing on late and bypassing the initial steps of metastasis. However, in an orthotopic model of neuroblastoma, which includes all steps of the metastatic process, CXCR4 is not sufficient to induce or increase metastasis, but fully manifest its growth promoting effects.
###end p 82
###begin p 83
The reason for the lack of increased invasion and metastasis upon CXCR4 overexpression in NB cells remained elusive. While for IGR-NB8 cells it could be argued that they lack essential invasive or metastatic properties, this cannot be true for IGR-N91 cell lines overexpressing CXCR4, since the parental line has already metastatic capacities. Also, MMP-2 and -9 appear not to be factors limiting invasion and metastatis in these cells. This finding indicate that neither CXCR4 expression nor MMP-2 and -9 are sufficient to confer invasive and metastatic properties to NB cells.
###end p 83
###begin p 84
###xml 425 429 425 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
It could also be argued that the time before sacrifice of animals bearing NB8-CXCR4-C3 tumours after only 53 days, was too short and not sufficient to allow metastases to develop. This appeared unlikely, since macroscopic liver metastases were observed in the N91-E2 group already after 49 days. Furthermore, based on our experience in this model, bone marrow metastases usually occur within 50 days after tumour engraftment [19].
###end p 84
###begin p 85
We could also rule out that NB8 clones expressed too low levels of CXCR4 to induce invasion or metastasis, as the levels of expression were comparable to that of the PC3-CXCR4 cells, which show enhanced invasive properties.
###end p 85
###begin p 86
###xml 71 78 71 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 345 353 345 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 395 402 395 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 673 674 673 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 729 730 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
In contrast, CXCR4 overexpression induced a remarkable enhancement of, in vivo tumour growth, representing the essential observation of this study. Both CXCR4 overexpressing cell lines NB8-CXCR4-C3 and N91-CXCR4-14 displayed a considerably faster growth compared to their respective controls. Even N91-CXCR4-14 cells which did not show enhanced in vitro growth, proliferate significantly faster in vivo, indicating that endogeneous CXCR4-mediated effects on growth can be further increased and are most likely dependent on the tumor environment. Interestingly, secondary growth was also enhanced: macroscopic liver metastases in the N91-CXCR4-14 were all larger than 500 mm3 whereas the N91-E2 metastases were smaller than 500 mm3. Such observation strengthens the hypothesis that CXCR4/CXCL12 axis participates in the promotion of in vivo NB cell proliferation, together with other micro environmental factors, which need to be identified.
###end p 86
###begin p 87
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 110 117 110 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
The impressive influence of CXCR4 on in vivo NB growth was further supported by CXCR4 knock-down experiments. In vivo, tumour growth of N91-shRNA-CS1 and N91-shRNA-CS2 clones with reduced endogenous CXCR4 was almost totally abrogated compared to N91-pAB303 control cells. This result confirms a role not only for exogenous but also for endogeneous CXCR4 in NB cell growth.
###end p 87
###begin p 88
###xml 68 76 68 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 411 415 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Taichman1">[22]</xref>
###xml 466 474 466 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 499 506 499 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 535 543 535 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Under normal culture conditions i.e. in the presence of 10% FCS the in vitro proliferation assays showed a moderately increased growth of 2/3 NB8-CXCR4 clones compared to mock transduced cells. This discrete growth promoting effect may be ligand independent, considering that serum contains low levels of CXCL12, or be a result of an autocrine signal from low amounts of CXC12 produced by NB cells, as reported [22]. However, the NB8-C3 clone, displaying a moderate in vitro and a strongly enhanced in vivo growth, showed an increased in vitro growth in response to CXC12, indicating that CXCL12/CXCR4 axis can promote NB cell growth in vitro.
###end p 88
###begin p 89
###xml 502 506 502 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Hatse1">[42]</xref>
###xml 881 889 881 889 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1012 1020 1012 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Moreover, NB8-CXCR4 cells were less sensitive to reduced serum concentration (2% FCS). This finding indicates that CXCR4 can, at least in part, compensate for serum depletion, and increases survival in stress conditions, a hallmark of malignancy. In NB8-CXCR4 cells CXCL12/CXCR4 activates ERK1/2, with oncogenic and tumour-promoting activities, consistent with the report by Hatse et al showing that endogenous CXCL12/CXCR4 signalling axis is critical for neuroblastoma cell survival and proliferation [42]. The pro-survival effect of CXCR4 observed in stress conditions may be due to the low amounts of CXCL12 produced by NB cells. The in vitro effect of CXCR4 on proliferation under reduced serum concentration was not observed for the IGR-N91 cell line, which may be due to the fact that the constitutive expression of CXCR4 in this cell line is already be sufficient to confer in vitro survival advantages. Indeed, both N91-shRNA-CS1 and N91-shRNA-CS2 CXCR4 silenced clones showed reduced cell proliferation in vitro in 10% serum and in reduced serum concentration.
###end p 89
###begin p 90
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Globally, our results show that exogeneous CXCR4 overexpression in IGR-N91 does not further increase their in vitro growth, migration and invasive properties, indicating that a subtle threshold of endogenous CXCR4 level necessary and sufficient for mediating growth, survival and migration is reached in these cells. In contrast, their in vivo growth could be further enhanced, probably by synergic signals provided by the tumour microenvironment.
###end p 90
###begin p 91
###xml 67 75 67 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 80 87 80 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 858 861 858 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Balkwill2">[9]</xref>
###xml 1165 1169 <span type="species:ncbi:10090">mice</span>
The difference observed between the CXCR4 growth-promoting effects in vitro and in vivo indeed suggests that CXCR4 participates to a more complex growth-promoting phenomenon involving the tumour microenvironment. The high levels of CXCL12 found in the primary tumour site (adrenal gland) and in a major site of metastasis in our model (the liver) support the notion that it may confer survival and proliferative advantages to the NB cells and is consistent with a critical role of tumour microenvironment in primary and secondary tumour growth. In addition to a possible paracrine effect on tumour growth, the high levels of CXCL12 measured in the primary site (adrenal gland), represents a unique situation to NB where CXCL12 in the adrenal gland could also serve to retain the malignant cells in the primary site, rather than encourage them to metastasise [9]. Nevertheless, some tumour cells, possibly equipped with unidentified particularly invasive characteristics, do escape the primary tumour and may then use the CXCR4/CXCL12 axis to specifically migrate toward CXCL12 producing organs such as the liver. Thus the large size of liver metastases observed in mice engrafted with N91-CXCR4-14 cells, also supports a CXCR4-mediated enhanced growth at secondary sites as at primary organs.
###end p 91
###begin p 92
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 478 482 478 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Joseph1">[19]</xref>
###xml 706 713 706 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
In conclusion, this in vivo and in vitro study reveals unique growth-promoting effect of the CXCR4/CXCL12 axis in NB, demonstrated by concordant CXCR4 gain and loss of function assays. This study also emphasizes the importance to study tumour growth and progression in orthotopic conditions. The role of the microenvironment in the CXCR4-mediated growth and the underlying explanation for the lack of increased metastatic spread can only be identified using an orthotopic model [19]. In particular, the differential expression levels of CXCL12 ligand in primary and secondary target sites clarifies the role of the CXCR4/CXCL12 system in NB progression: it strongly enhances cell growth without increasing in vivo invasion.
###end p 92
###begin p 93
###xml 8 16 8 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 297 301 297 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Nevo1">[43]</xref>
Further in vitro molecular investigations will be needed to identify the growth and survival pathways involved in such CXCR4/CXCL12 responses. In particular, while some CXCR4-overexpressing related proteins have been already reported, a global CXCR4-mediated expression profile will be identified [43]. Key molecules of the CXCR4 signalling pathway could be new targets for specific NB therapeutic tools.
###end p 93
###begin title 94
Supporting Information
###end title 94
###begin p 95
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0001016-Uhm1">[44]</xref>
Zymographic assay of MMP-2 activity in NB cells culture media. Equal cell number (0.8x105) of different cell lines was plated in SFM. After 12 hours starvation, medium was collected and matrix metalloproteinase MMP-2, and MMP-9 activities were evaluated by gelatine zymography as described [44]. Gels were stained with Coomassie blue to check for equal sample loading. MMP-2 activity is represented as a band of gelatinolysis at 72 KDa. MMP-9 activity was not detected (not shown).
###end p 95
###begin p 96
(0.14 MB TIF)
###end p 96
###begin p 97
Click here for additional data file.
###end p 97
###begin p 98
###xml 116 123 116 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
We are grateful for the help of J. Morizet UPRES EA3535, Institut Gustave Roussy, Villejuif Cedex, France, with the in vivo experiments. We also thank Prof. N. Fujii, (Kyoto, Japan), for gift of the CXCR4 blocker (TN14003 inhibitor) and Prof. I Stamenkovic, (IUP, CHUV, Lausanne) for helpful discussions. We acknowledge the help of Y. Monnier (Division of Experimental Oncology, Lausanne Cancer Centre, Lausanne, Switzerland) for invasion assays.
###end p 98
###begin title 99
References
###end title 99
###begin article-title 100
Neuroblastoma: biological insights into a clinical enigma.
###end article-title 100
###begin article-title 101
The hallmarks of cancer.
###end article-title 101
###begin article-title 102
The microenvironment of the tumour-host interface.
###end article-title 102
###begin article-title 103
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human chemokines: an update.
###end article-title 103
###begin article-title 104
Chemokines in tissue-specific and microenvironment-specific lymphocyte homing.
###end article-title 104
###begin article-title 105
Chemokines: a new classification system and their role in immunity.
###end article-title 105
###begin article-title 106
Involvement of chemokine receptors in breast cancer metastasis.
###end article-title 106
###begin article-title 107
Cancer and the chemokine network.
###end article-title 107
###begin article-title 108
The significance of cancer cell expression of the chemokine receptor CXCR4.
###end article-title 108
###begin article-title 109
Chemokine biology in cancer.
###end article-title 109
###begin article-title 110
###xml 63 68 <span type="species:ncbi:9606">human</span>
Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.
###end article-title 110
###begin article-title 111
Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastoma.
###end article-title 111
###begin article-title 112
###xml 31 36 <span type="species:ncbi:9606">human</span>
CXCL12 does not attract CXCR4+ human metastatic neuroblastoma cells: clinical implications.
###end article-title 112
###begin article-title 113
VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche.
###end article-title 113
###begin article-title 114
Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis.
###end article-title 114
###begin article-title 115
###xml 79 83 <span type="species:ncbi:10090">mice</span>
Orthotopic models are necessary to predict therapy of transplantable tumors in mice.
###end article-title 115
###begin article-title 116
###xml 42 47 <span type="species:ncbi:9606">human</span>
Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion.
###end article-title 116
###begin article-title 117
###xml 44 52 <span type="species:ncbi:9606">patients</span>
T-cell receptor repertoire in neuroblastoma patients.
###end article-title 117
###begin article-title 118
###xml 115 120 <span type="species:ncbi:9606">human</span>
In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenografts.
###end article-title 118
###begin article-title 119
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Coactivation of the MDR1 and MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse.
###end article-title 119
###begin article-title 120
A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma.
###end article-title 120
###begin article-title 121
Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
###end article-title 121
###begin article-title 122
###xml 12 15 <span type="species:ncbi:10116">rat</span>
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
###end article-title 122
###begin article-title 123
The PAX5 oncogene is expressed in N-type neuroblastoma cells and increases tumorigenicity of a S-type cell line.
###end article-title 123
###begin article-title 124
Expressed isolated integrin beta1 subunit cytodomain induces endothelial cell death secondary to detachment.
###end article-title 124
###begin article-title 125
Pleiotrophin, a candidate gene for poor tumor vasculature and in vivo neuroblastoma sensitivity to irinotecan.
###end article-title 125
###begin article-title 126
Deficiency in the Wiskott-Aldrich protein induces premature proplatelet formation and platelet production in the bone marrow compartment.
###end article-title 126
###begin article-title 127
Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent.
###end article-title 127
###begin article-title 128
A system for stable expression of short interfering RNAs in mammalian cells.
###end article-title 128
###begin article-title 129
Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis.
###end article-title 129
###begin article-title 130
Persistent inhibition of FLIP(L) expression by lentiviral small hairpin RNA delivery restores death-receptor-induced apoptosis in neuroblastoma cells.
###end article-title 130
###begin article-title 131
Induction of an interferon response by RNAi vectors in mammalian cells.
###end article-title 131
###begin article-title 132
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Effect of YM529 on a model of mandibular invasion by oral squamous cell carcinoma in mice.
###end article-title 132
###begin article-title 133
CXCR4 expression mediates glioma cell invasiveness.
###end article-title 133
###begin article-title 134
The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases.
###end article-title 134
###begin article-title 135
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
###end article-title 135
###begin article-title 136
###xml 39 47 <span type="species:ncbi:9606">patients</span>
Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome.
###end article-title 136
###begin article-title 137
###xml 90 95 <span type="species:ncbi:9606">human</span>
CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer.
###end article-title 137
###begin article-title 138
Chemokines and disease.
###end article-title 138
###begin article-title 139
Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma.
###end article-title 139
###begin article-title 140
###xml 70 75 <span type="species:ncbi:9606">human</span>
Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer.
###end article-title 140
###begin article-title 141
###xml 3 8 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
X4 HIV-1 induces neuroblastoma cell death by interference with CXCL12/CXCR4 interaction.
###end article-title 141
###begin article-title 142
The tumor microenvironment: CXCR4 is associated with distinct protein expression patterns in neuroblastoma cells.
###end article-title 142
###begin article-title 143
Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C.
###end article-title 143
###begin p 144
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 144
###begin p 145
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work has been supported by grants from the Swiss National Scientific Foundation (JMJ and NG), FORCE foundation, (NG, RM and JMJ), a UICC (Union Internationale Contre le Cancer) Yamagiwa-Yoshida Memorial International Cancer Study Grant (RM), and an Oncosuisse grant (to RM).
###end p 145

